Antiviral role of toll-like receptors and cytokines against the new 2009 H1N1 virus infection

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1163-1172

  Liu, Ye ^a   Chen, Hong ^a   Sun, Yajiao ^a   Chen, Fuhui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; H1N1; Immune; Th1; Toll like receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFANT; INNATE IMMUNITY; LABORATORY TEST; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATIENT CODING; PREGNANT WOMAN; PRESCHOOL CHILD; PROTEIN EXPRESSION; PUERPERIUM; SCHOOL CHILD; TH1 CELL; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; PATHOGENICITY; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

BACTERIA (MICROORGANISMS); ORTHOMYXOVIRIDAE;

ANALYSIS OF VARIANCE; CHINA; CYTOKINES; DISEASE SUSCEPTIBILITY; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TOLL-LIKE RECEPTORS;

EID: 84860352055     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0846-7     Document Type: Article

References (22)

1. McCullers JA (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571-582 (Pubitemid 44134311)
2. Hilleman MR (2002) Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20:3068-3087
3. Webster RG, Govorkova EA (2006) H5N1 influenza-continuing evolution and spread. N Engl J Med 355:2174-2177
4. Perez-Padilla R, de la Rosa-Zamboni D et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361(7):680-689
5. Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197-201
6. Van der Meer FJ, Orsel K, Barkema HW (2010) The new influenza A H1N1 virus: balancing on the interface of humans and animals. Can Vet J 51(1):56-62
7. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS et al (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605-2615
8. Shahsavandi S, Salmanian AH, Ghorashi SA et al (2010) Specific subtyping of Influenza A virus using a recombinant hemaggluti-nin protein expressed in baculovirus. Mol Biol Rep 38(5):3293-3298
9. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361:680-689
10. Zhang C, Wu X, Zhao Y, Deng Z, Qian G (2011) SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells. Mol Biol Rep 38(1):601-609
11. Guillot L, Goffic RL, Bloch S et al (2005) Involvement of tolllike receptor 3 in the immune response of lung epithelial cells to double stranded RNA and influenza A virus. J Biol Chem 280:5571-5580 (Pubitemid 40280035)
12. Liu L, Botos I, Wang Y et al (2008) Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320:379-381 (Pubitemid 351555661)
13. Doherty PC, Turner SJ, Webby RG, Thomas PG (2006) Influenza and the challenge for immunology. Nat Immunol 7:449-455
14. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M et al (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323 (Pubitemid 46122819)
15. World Health Organization (2009) Global alert and response, pandemic (H1N1) 2009, frequently asked questions: what is phase 6? http://www.who.int/ csr/disease/swineflu/frequently-asked- questions/levels-pandemic-alert/en/index. html. Accessed 8 Oct
16. Centers for Disease Control, Prevention (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58(19):521-524
17. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group (2009) Factors associated with death or hospi-talization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 302(17):1896-1902
18. Dessing MC, van der Sluijs KF, Florquin S, Akira S, van der Poll T (2007) Toll-like receptor 2 does not contribute to host response during post influenza pneumococcal pneumonia. Am J Respir Cell Mol Biol 36(5):609-614 (Pubitemid 46676720)
19. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006) Detrimental contribution of the Toll-like receptor (TLR) 3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2(6):e53
20. Wu Y, Wang Y, Zhan J (2009) Effects of remifentanyl and fentanyl on LPS-induced cytokine release in human whole blood in vitro. Mol Biol Rep 36(5):1113-1117
21. Heil F, Hemmi H, Hochrein H et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529 (Pubitemid 38314424)
22. Baldwin SL, Shaverdian N, Goto Y, Duthie MS, Raman VS, Evers T, Mompoint F, Vedvick TS, Bertholet S, Coler RN, Reed SG (2009) Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine 27(43):5956-5963